Nurse Anesthetist - CR in Warrensburg, MO Accepting Medicare

9 Nurse Anesthetist - CR nurses found. Showing 1 - 9

Jacqueline Ann Sheehan, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 70 Sw 100th Rd, Warrensburg, MO 64093 Phone: 660-422-2646

Scott C. Smith, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 403 Burkarth Rd, Warrensburg, MO 64093 Phone: 660-747-2500

Katie Jolliffe, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 403 Burkarth Rd, Warrensburg, MO 64093 Phone: 660-424-0995

Janice Lynne Darling, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 403 Burkarth Rd, Warrensburg, MO 64093 Phone: 660-747-2500    Fax: 660-747-8455

Mr. Cody D Johnston, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 403 Burkarth Rd, Warrensburg, MO 64093 Phone: 660-747-2500    Fax: 660-747-8455

Braden M Spangler, DNAP Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 403 Burkarth Rd, Warrensburg, MO 64093 Phone: 660-747-2500

Kristena Jordan Scott, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 403 Burkarth Rd, Warrensburg, MO 64093 Phone: 660-747-2500

Seth Evans, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 403 Burkarth Rd, Warrensburg, MO 64093 Phone: 660-747-2500

Andrew Jordan, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 403 Burkarth Rd, Warrensburg, MO 64093 Phone: 660-747-2500

News Archive

Exalenz Bioscience initiates BreathID clinical study to detect primary liver cancer

Exalenz Bioscience, a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced the initiation of a clinical study designed to investigate its BreathID test to non-invasively detect primary liver cancer, also known as Hepatocellular Carcinoma (HCC).

Genta first-quarter net loss increases to $166.6 million

Genta Incorporated today announced financial results for the quarter ended March 31, 2010.

California Bioscience Business Roundtable event hosted at the Quadrus Conference Center

Today a group of national and California-based partners hosted the California Bioscience Business Roundtable (BBR) event at the Quadrus Conference Center in Menlo Park. The event also featured Sam Youngman, the White Correspondent for The Hill newspaper, who provided a reporter's front row perspective on the unfolding health reform debate in Washington, D.C.

Celera to use Medical Therapies' midkine patent portfolio for development of novel lung cancer diagnostics

Celera Corporation, a health care company focused on genetics, and Medical Therapies Limited (ASX:MTY), a biotechnology company developing midkine-related diagnostic and therapeutic products, have entered into an exclusive license agreement for the use of MTY's midkine patent portfolio for the development of novel lung cancer diagnostics.

Read more Medical News

› Verified 6 days ago